Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Opinion in Immunology
|
January 24, 2014
Dendritic cells in asthma
Mary J van Helden, Bart N Lambrecht
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
January 10, 2015
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen, Britt Callebaut, Mary J Van Helden, et al.
EMBO Molecular Medicine
|
February 16, 2018
Role of NKp46<sup>+</sup> natural killer cells in house dust mite-driven asthma
Eline Haspeslagh, Mary J van Helden, Kim Deswarte, et al.
Scientific Reports
|
June 16, 2017
Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain
Lana Vandersarren, Cedric Bosteels, Manon Vanheerswynghels, et al.
The Journal of Experimental Medicine
|
July 13, 2019
The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF
Jessica Vetters, Mary J van Helden, Sigrid Wahlen, et al.
Immunity
|
May 12, 2020
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
Cedric Bosteels, Katrijn Neyt, Manon Vanheerswynghels, et al.
The Journal of Experimental Medicine
|
October 28, 2015
Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection
Mary J van Helden, Steven Goossens, Cécile Daussy, et al.
NPJ Vaccines
|
December 22, 2017
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia, Catherine Collignon, Caroline Hervé, et al.
NPJ Vaccines
|
March 28, 2018
Erratum: Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia, Catherine Collignon, Caroline Hervé, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2023
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
Mary J van Helden, Seline A Zwarthoff, Roel J Arends, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Opinion in Immunology
|
January 24, 2014
Dendritic cells in asthma
Mary J van Helden, Bart N Lambrecht
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
January 10, 2015
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen, Britt Callebaut, Mary J Van Helden, et al.
EMBO Molecular Medicine
|
February 16, 2018
Role of NKp46<sup>+</sup> natural killer cells in house dust mite-driven asthma
Eline Haspeslagh, Mary J van Helden, Kim Deswarte, et al.
Scientific Reports
|
June 16, 2017
Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain
Lana Vandersarren, Cedric Bosteels, Manon Vanheerswynghels, et al.
The Journal of Experimental Medicine
|
July 13, 2019
The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF
Jessica Vetters, Mary J van Helden, Sigrid Wahlen, et al.
Immunity
|
May 12, 2020
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
Cedric Bosteels, Katrijn Neyt, Manon Vanheerswynghels, et al.
The Journal of Experimental Medicine
|
October 28, 2015
Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection
Mary J van Helden, Steven Goossens, Cécile Daussy, et al.
NPJ Vaccines
|
December 22, 2017
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia, Catherine Collignon, Caroline Hervé, et al.
NPJ Vaccines
|
March 28, 2018
Erratum: Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia, Catherine Collignon, Caroline Hervé, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2023
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
Mary J van Helden, Seline A Zwarthoff, Roel J Arends, et al.
Page
of 1